NeOnc claims that its novel intranasal delivery platform will be able to bypass the blood-brain barrier and better target ...

Trevi Therapeutics has finished enrolling subjects in a trial of investigational Haduvio for treating chronic cough in IPF ...

Early results from the company’s single-arm trial saw the therapy able to partially repair the chemical responsible for ...

The Phase II trial comes as the US Food and Drug Administration grants an investigational new drug application for cannabis ...

In an anonymous post in the BMJ, the author claims that words relating to DEI could lead to grants being taken away.

The CoTikiS trial’s 10-week results from the 50-week ulcerative colitis trial saw as an endoscopic improvement rate of 32% in ...

Sanofi and Teva Pharmaceuticals have reported new outcomes from the Phase IIb RELIEVE UCCD trial of duvakitug.

Ensho has presented additional data supporting NSHO-101, also referred to as EA1080, as an oral one-time-a-day treatment for ...

The news follows just a week after the start-up secured $90m in a Series A financing round to propel its pipeline candidates, including BBT002. Credit: Shutterstock / savitskaya iryna. Bambusa ...

The trial involves the pancreatic cancer therapy, glufosfamide. Credit: SewCreamStudio/Shutterstock. BullFrog AI Holdings has announced a partnership agreement with ...

The trial is expected to enrol 40 subjects across 25 sites globally in the IO-108 part of the study. Credit: New Africa/Shutterstock. Immune-Onc Therapeutics has dosed the first subject in the Phase ...

Current paediatric standard-of-care for galactosemia is a galactose-free diet. Image credit: Shutterstock / Photoongraphy. Nearly three months after an experimental treatment for classic galactosemia ...